(-)-epigallocatechin 3-gallate multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CSNK2A2 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK2A2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CSNK2A2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK2A2 mRNA CTD PMID:17942748 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CSNK2A2 mRNA CTD PMID:15721199 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK2A2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CSNK2A2 mRNA CTD PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CSNK2A2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CSNK2A2 mRNA CTD PMID:17942748 2-hydroxypropanoic acid decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CSNK2A2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO CSNK2A2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of CSNK2A2 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of CSNK2A2 protein CTD PMID:31675489 4,4'-sulfonyldiphenol multiple interactions ISO Csnk2a2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK2A2 mRNA CTD PMID:36041667 5-aza-2'-deoxycytidine increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Decitabine results in increased expression of CSNK2A2 mRNA and Decitabine results in increased expression of CSNK2A2 protein CTD PMID:19027835 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of CSNK2A2 mRNA CTD PMID:27915011 6-propyl-2-thiouracil decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of CSNK2A2 mRNA CTD PMID:30047161 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CSNK2A2 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CSNK2A2 mRNA CTD PMID:33167477 amitrole decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Amitrole results in decreased expression of CSNK2A2 mRNA CTD PMID:30047161 aristolochic acid A increases expression ISO CSNK2A2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CSNK2A2 protein CTD PMID:33212167 aristolochic acid A decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of CSNK2A2 mRNA CTD PMID:33212167 atrazine increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Atrazine results in increased expression of CSNK2A2 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CSNK2A2 mRNA CTD PMID:22228805 bisphenol A increases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CSNK2A2 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO Csnk2a2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK2A2 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CSNK2A2 protein CTD PMID:31675489 and PMID:37567409 bisphenol A affects expression ISO CSNK2A2 (Homo sapiens) 6480464 bisphenol A affects the expression of CSNK2A2 mRNA CTD PMID:30903817 bisphenol F multiple interactions ISO Csnk2a2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK2A2 mRNA CTD PMID:36041667 buspirone increases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Buspirone results in increased expression of CSNK2A2 mRNA CTD PMID:24136188 C60 fullerene decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of CSNK2A2 mRNA CTD PMID:19167457 cadmium dichloride decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of CSNK2A2 mRNA CTD PMID:25851441 caffeine decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Caffeine results in decreased expression of CSNK2A2 mRNA CTD PMID:20864626 carbamazepine affects expression ISO CSNK2A2 (Homo sapiens) 6480464 Carbamazepine affects the expression of CSNK2A2 mRNA CTD PMID:24752500 chloroprene increases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Chloroprene results in increased expression of CSNK2A2 mRNA CTD PMID:23125180 cisplatin multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of CSNK2A2 mRNA CTD PMID:21858171 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CSNK2A2 mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO CSNK2A2 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of CSNK2A2 mRNA CTD PMID:19320972 and PMID:19376846 copper atom multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CSNK2A2 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CSNK2A2 mRNA CTD PMID:30911355 coumestrol decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Coumestrol results in decreased expression of CSNK2A2 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of CSNK2A2 mRNA CTD PMID:25562108 daidzein affects expression EXP 6480464 daidzein affects the expression of CSNK2A2 mRNA CTD PMID:15721199 diazinon increases methylation ISO CSNK2A2 (Homo sapiens) 6480464 Diazinon results in increased methylation of CSNK2A2 gene CTD PMID:22964155 diclofenac affects expression ISO CSNK2A2 (Homo sapiens) 6480464 Diclofenac affects the expression of CSNK2A2 mRNA CTD PMID:24752500 diethylstilbestrol affects expression EXP 6480464 Diethylstilbestrol affects the expression of CSNK2A2 mRNA CTD PMID:15721199 dorsomorphin multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSNK2A2 mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CSNK2A2 mRNA CTD PMID:16243910 doxorubicin decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CSNK2A2 mRNA CTD PMID:29803840 ethyl methanesulfonate increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of CSNK2A2 mRNA CTD PMID:23649840 fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of CSNK2A2 mRNA CTD PMID:34813904 flutamide increases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Flutamide results in increased expression of CSNK2A2 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK2A2 mRNA CTD PMID:22206623 gentamycin increases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of CSNK2A2 mRNA CTD PMID:22061828 ivermectin decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of CSNK2A2 protein CTD PMID:32959892 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CSNK2A2 mRNA CTD PMID:22609695 lead(0) decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Lead results in decreased expression of CSNK2A2 mRNA CTD PMID:19921347 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of CSNK2A2 mRNA CTD PMID:34813904 methimazole decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Methimazole results in decreased expression of CSNK2A2 mRNA CTD PMID:30047161 methoxyacetic acid decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 methoxyacetic acid results in decreased expression of CSNK2A2 mRNA CTD PMID:20864626 methoxyacetic acid affects expression ISO Csnk2a2 (Rattus norvegicus) 6480464 methoxyacetic acid affects the expression of CSNK2A2 mRNA CTD PMID:20864626 methyl methanesulfonate increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of CSNK2A2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 methylmercuric chloride results in decreased expression of CSNK2A2 mRNA CTD PMID:20864626 Monobutylphthalate decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 monobutyl phthalate results in decreased expression of CSNK2A2 mRNA CTD PMID:20864626 N-methyl-4-phenylpyridinium multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CSNK2A2 mRNA] CTD PMID:12710931 N-Vinyl-2-pyrrolidone multiple interactions ISO Csnk2a2 (Rattus norvegicus) 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CSNK2A2 mRNA CTD PMID:22037397 nickel dichloride affects expression ISO Csnk2a2 (Rattus norvegicus) 6480464 nickel chloride affects the expression of CSNK2A2 mRNA CTD PMID:22546817 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CSNK2A2 mRNA CTD PMID:34911549 ozone multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of CSNK2A2 mRNA CTD PMID:35430440 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CSNK2A2 mRNA CTD PMID:17562736 paraquat increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Paraquat results in increased expression of CSNK2A2 protein CTD PMID:26649146 phytoestrogen affects expression EXP 6480464 Phytoestrogens affects the expression of CSNK2A2 mRNA CTD PMID:15721199 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CSNK2A2 mRNA CTD PMID:19710929 piroxicam multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of CSNK2A2 mRNA CTD PMID:21858171 potassium chromate multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CSNK2A2 mRNA CTD PMID:22079256 potassium chromate increases expression ISO CSNK2A2 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of CSNK2A2 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of CSNK2A2 mRNA CTD PMID:30047161 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of CSNK2A2 mRNA CTD PMID:21278054 quercetin increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Quercetin results in increased expression of CSNK2A2 mRNA CTD PMID:21632981 quercitrin affects expression ISO CSNK2A2 (Homo sapiens) 6480464 quercitrin affects the expression of CSNK2A2 mRNA CTD PMID:25193878 rac-lactic acid decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CSNK2A2 mRNA CTD PMID:30851411 resveratrol increases expression ISO CSNK2A2 (Homo sapiens) 6480464 resveratrol results in increased expression of CSNK2A2 mRNA CTD PMID:19371625 resveratrol decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Resveratrol results in decreased expression of CSNK2A2 mRNA CTD PMID:33775663 rotenone increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Rotenone results in increased expression of CSNK2A2 mRNA CTD PMID:32368861 SB 431542 multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSNK2A2 mRNA CTD PMID:27188386 sodium arsenite increases expression ISO CSNK2A2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CSNK2A2 mRNA and sodium arsenite results in increased expression of CSNK2A2 protein CTD PMID:18572023 sodium arsenite multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 sodium arsenite promotes the reaction [CSNK2A2 protein binds to CAPRIN1 protein] CTD PMID:33939924 staurosporine affects expression EXP 6480464 Staurosporine affects the expression of CSNK2A2 mRNA CTD PMID:15721199 sulfadimethoxine decreases expression ISO Csnk2a2 (Rattus norvegicus) 6480464 Sulfadimethoxine results in decreased expression of CSNK2A2 mRNA CTD PMID:30047161 sulindac increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Sulindac results in increased expression of CSNK2A2 mRNA CTD PMID:11906190 sunitinib increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Sunitinib results in increased expression of CSNK2A2 mRNA CTD PMID:31533062 thapsigargin increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Thapsigargin results in increased expression of CSNK2A2 mRNA CTD PMID:22378314 trichostatin A decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of CSNK2A2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO CSNK2A2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSNK2A2 mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CSNK2A2 mRNA CTD PMID:28973697 tunicamycin increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Tunicamycin results in increased expression of CSNK2A2 mRNA CTD PMID:22378314 urethane increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Urethane results in increased expression of CSNK2A2 mRNA CTD PMID:28818685 valproic acid increases expression ISO CSNK2A2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CSNK2A2 mRNA CTD PMID:29154799 valproic acid affects expression ISO CSNK2A2 (Homo sapiens) 6480464 Valproic Acid affects the expression of CSNK2A2 mRNA CTD PMID:25979313 vanadium atom decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Vanadium results in decreased expression of CSNK2A2 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO CSNK2A2 (Homo sapiens) 6480464 Vanadium results in decreased expression of CSNK2A2 mRNA CTD PMID:19000753 vinclozolin affects expression ISO Csnk2a2 (Rattus norvegicus) 6480464 vinclozolin affects the expression of CSNK2A2 mRNA CTD PMID:19015723